Exacerbations in patients with chronic obstructive pulmonary disease receiving physical therapy: A cohort-nested randomised controlled trial

BMC Pulmonary Medicine

Volumn 14, Issue 1, 2014, Pages

  Beekman, Emmylou ^a,b   Mesters, Ilse ^a   Hendriks, Erik J M ^c   Muris, Jean W M ^a   Wesseling, Geertjan ^d   Evers, Silvia M A A ^a,e   Asijee, Guus M ^a,f   Fastenau, Annemieke ^a   Hoffenkamp, Hannah N ^g   Gosselink, Rik ^h,i   van Schayck, Onno C P ^a   de Bie, Rob A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Physical Therapy Section in Multidisciplinary Centre ParaMedisch Centrum Sittard Zuid   (Netherlands)

^c Physical Therapy Practice Fysiotherapie Maasstaete   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^f BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^g TILBURG UNIVERSITY   (Netherlands)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chronic obstructive pulmonary disease (MESH); Cohort studies (MESH); Comorbidity (MESH); Costs and cost analysis (MESH); Disease exacerbation (MESH); Exercise therapy (MESH); Physical therapy modalities (MESH); Physiotherapy; Pulmonary rehabilitation; Quality of life (MESH); Randomized controlled trial (MESH)

Indexed keywords

BRONCHODILATING AGENT;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; ECONOMIC EVALUATION; EXERCISE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEALTH INSURANCE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MOTIVATION; MUCUS; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PHYSIOTHERAPIST; PHYSIOTHERAPY; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REIMBURSEMENT; SHAM PROCEDURE; SMOKING; AGED; ARTIFICIAL VENTILATION; CASE CONTROL STUDY; DISEASE COURSE; FEMALE; KINESIOTHERAPY; LIFESTYLE; LUNG FUNCTION TEST; MALE; MIDDLE AGED; NETHERLANDS; PATIENT COMPLIANCE; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINGLE BLIND PROCEDURE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; CASE-CONTROL STUDIES; DISEASE PROGRESSION; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; NETHERLANDS; PATIENT COMPLIANCE; PHYSICAL THERAPY MODALITIES; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; RESPIRATORY THERAPY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84900475877     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-14-71     Document Type: Article

References (55)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management, and prevention of COPD. 2011, http://www.goldcopd.org/, Global Initiative for Chronic Obstructive Lung Disease (GOLD).
2. World Health Organization The global burden of disease: 2004 update. 2008, http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf, World Health Organization.
3. Decramer M, De Benedetto F, Del Ponte A, Marinari S. Systemic effects of COPD. Respir Med 2005, 99(B):S3-S10.
4. Barnes PJ, Stockley RA. COPD: current therapeutic interventions and future approaches. Eur Respir J 2005, 25(6):1084-1106. 10.1183/09031936.05.00139104, 15929966.
5. Spruit MA. Enhanced physiotherapy management of acute exacerbations of chronic obstructive pulmonary disease. Chron Respir Dis 2005, 2(3):117-119. 10.1191/1479972305cd083ed, 16281434.
6. Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000, 117(2 Suppl):5S-9S.
7. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987, 106(2):196-204. 10.7326/0003-4819-106-2-196, 3492164.
8. Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P, Bouillon R, Decramer M. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003, 58(9):752-756. 10.1136/thorax.58.9.752, 1746817, 12947130.
9. Puhan MA, Schunemann HJ, Frey M, Scharplatz M, Bachmann LM. How should COPD patients exercise during respiratory rehabilitation? comparison of exercise modalities and intensities to treat skeletal muscle dysfunction. Thorax 2005, 60(5):367-375. 10.1136/thx.2004.033274, 1758898, 15860711.
10. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care 2003, 48(12):1204-1213. discussion 1213-1205.
11. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 2006, 129(3):536-544. 10.1378/chest.129.3.536, 16537849.
12. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006, 61(9):772-778. 10.1136/thx.2006.060145, 2117100, 16738033.
13. Spruit MA, Polkey MI, Celli B, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agusti A, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Crim CC, Yates J, Wouters EF. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc 2012, 13(3):291-297. 10.1016/j.jamda.2011.06.009, 21778120.
14. Chavannes N, Vollenberg JJ, van Schayck CP, Wouters EF. Effects of physical activity in mild to moderate COPD: a systematic review. Br J Gen Pract 2002, 52(480):574-578. 1314362, 12120732.
15. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006, 4, CD003793.
16. Man WD, Polkey MI, Donaldson N, Gray BJ, Moxham J. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 2004, 329(7476):1209. 10.1136/bmj.38258.662720.3A, 529363, 15504763.
17. Murphy N, Bell C, Costello RW. Extending a home from hospital care programme for COPD exacerbations to include pulmonary rehabilitation. Respir Med 2005, 99(10):1297-1302. 10.1016/j.rmed.2005.02.033, 16140230.
18. Almeida P, Rodrigues F. Exercise training modalities and strategies to improve exercise performance in patients with respiratory disease. Rev Port Pneumol 2014, 20(1):36-41. 10.1016/j.rppneu.2013.10.004, 24290562.
19. Troosters T, Casaburi R, Gosselink R, Decramer M. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005, 172(1):19-38. 10.1164/rccm.200408-1109SO, 15778487.
20. Puente-Maestu L, Tena T, Trascasa C, Perez-Parra J, Godoy R, Garcia MJ, Stringer WW. Training improves muscle oxidative capacity and oxygenation recovery kinetics in patients with chronic obstructive pulmonary disease. Eur J Appl Physiol 2003, 88(6):580-587. 10.1007/s00421-002-0743-9, 12560958.
21. Patessio A, Carone M, Ioli F, Donner CF. Ventilatory and metabolic changes as a result of exercise training in COPD patients. Chest 1992, 101(5 Suppl):274S-278S.
22. Casaburi R, ZuWallack R. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med 2009, 360(13):1329-1335. 10.1056/NEJMct0804632, 19321869.
23. Porszasz J, Emtner M, Goto S, Somfay A, Whipp BJ, Casaburi R. Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD. Chest 2005, 128(4):2025-2034. 10.1378/chest.128.4.2025, 16236851.
24. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011, 10, CD005305.
25. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 2007, 370(9589):786-796. 10.1016/S0140-6736(07)61382-8, 17765528.
26. Gosselink R. Respiratory rehabilitation: improvement of short- and long-term outcome. Journal 2002, 20(1):4-5. Editorial.
27. Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM, . Estudi del Factors de Risc d'Aguditzacio de la Mi Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003, 58(2):100-105. 10.1136/thorax.58.2.100, 1746561, 12554887, Estudi del Factors de Risc d'Aguditzacio de la Mi.
28. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159(1):158-164. 10.1164/ajrccm.159.1.9803117, 9872834.
29. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997, 10(2):417-423. 10.1183/09031936.97.10020417, 9042643.
30. Guell R, Casan P, Belda J, Sangenis M, Morante F, Guyatt GH, Sanchis J. Long-term effects of outpatient rehabilitation of COPD: a randomized trial. Chest 2000, 117(4):976-983. 10.1378/chest.117.4.976, 10767227.
31. Foglio K, Bianchi L, Ambrosino N. Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? a 2-year controlled study. Chest 2001, 119(6):1696-1704. 10.1378/chest.119.6.1696, 11399693.
32. Davidson WJ, Verity WS, Traves SL, Leigh R, Ford GT, Eves ND. Effect of incremental exercise on airway and systemic inflammation in patients with COPD. J Appl Physiol 2012, 112(12):2049-2056. 10.1152/japplphysiol.01615.2011, 22500008.
33. Kirsten DK, Taube C, Lehnigk B, Jorres RA, Magnussen H. Exercise training improves recovery in patients with COPD after an acute exacerbation. Respir Med 1998, 92(10):1191-1198. 10.1016/S0954-6111(98)90420-6, 9926148.
34. Puhan MA, Scharplatz M, Troosters T, Steurer J. Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality - a systematic review. Respir Res 2005, 6:54. 10.1186/1465-9921-6-54, 1164434, 15943867.
35. Gosselink RA, Langer D, Burtin C, Probst VS, Hendriks HJM, van der Schans CP, Paterson WJ, Verhoef-van Wijk MCE, Straver RV, Klaassen M, Troosters T, Decramer M, Ninane V, Delguste P, Muris J, Wempe J. KNGF-guideline for physical therapy in chronic obstructive pulmonary disease. Royal Dutch Society for Physical Therapy 2008, 118(4):1-60.
36. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161(5):1608-1613. 10.1164/ajrccm.161.5.9908022, 10806163.
37. Decramer M, Nici L, Nardini S, Reardon J, Rochester CL, Sanguinetti CM, Troosters T. Targeting the COPD exacerbation. Respir Med 2008, 102(Suppl 1):S3-S15.
38. Kosmas EN, Vey V, Fraggou M, Papaneofytou I, Athanassa Z, Koutsoukou A, Vogiatzis I, Georgiadou O, Koulouris N, Orfanidou D, Roussos C. Effects of pulmonary rehabilitation on exacerbation rate, hospitalizations, length of hospital stay and public health economics in patients with moderate-to-severe chronic obstructive pulmonary disease. Chest 2005, 128(4_MeetingAbstracts):254S.
39. Kelsey JL, Whittemore AS, Evans AS, Thompson WD. Methods in Observational Epidemiology 1996, New York: Oxford University Press, 2.
40. Decision Support Systems LP Researcher's toolkit, sample size calculator (Percentages, two samples). https://www.dssresearch.com/KnowledgeCenter/toolkitcalculators.aspx, Decision Support Systems LP.
41. Smeele IJM, Van Weel C, Van Schayck CP, Van der Molen T, Thoonen B, Schermer T, Sachs APE, Muris JWM, Chavannes NH, Kolnaar BGM, Grol MH, Geijer RMM. The Dutch college of general practitioners (NHG) practice guideline COPD [NHG-standaard COPD]. Huisarts Wet 2007, 50(8):362-379.
42. Gosselink R, Decramer M. Rehabilitation in Chronic Obstructive Pulmonary Disease [Revalidatie bij chronische obstructieve longziekten] 2001, Elsevier Gezondheidszorg: Maarssen.
43. Ministry of Health, Welfare and Sport Youth monitor, definitions - Dutch healthy exercise norm: NNGB (Nederlandse Norm Gezond Bewegen). 2008, http://jeugdmonitor.cbs.nl/en-GB/menu/inlichtingen/begrippen/nngb.htm, Ministry of Health, Welfare and Sport.
44. Van der Leeden M, Staal JB, Beekman E, Hendriks H, Mesters I, de Rooij M, de Vries N, Werkman M, de Graaf-Peters V, de Bie R, Hulzebos E, Nijhuis-van der Sanden R, Dekker J. Development of a framework to describe goals and content of exercise interventions in physical therapy: a mixed method approach including a systematic review. Phys Ther Rev 2014, 19(1):1-14.
45. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl 2003, 41:46s-53s.
46. Caramori G, Adcock IM, Papi A. Clinical definition of COPD exacerbations and classification of their severity. South Med J 2009, 102(3):277-282. 10.1097/SMJ.0b013e3181836b73, 19204646.
47. Walters EH, Walters J, Wills KE, Robinson A, Wood-Baker R. Clinical diaries in COPD: compliance and utility in predicting acute exacerbations. Int J Chron Obstruct Pulmon Dis 2012, 7:427-435. 3402058, 22848156.
48. Effing T, Kerstjens H, van der Valk P, Zielhuis G, van der Palen J. (Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax 2009, 64(11):956-962. 10.1136/thx.2008.112243, 19736179.
49. Donaldson GC, Seemungal TA, Patel IS, Lloyd-Owen SJ, Wilkinson TM, Wedzicha JA. Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J 2003, 22(6):931-936. 10.1183/09031936.03.00038303, 14680081.
50. Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2005, 86(10):1979-1985. 10.1016/j.apmr.2005.04.016, 16213242.
51. Andrews AW, Thomas MW, Bohannon RW. Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys Ther 1996, 76(3):248-259.
52. AmericanThoracicSociety Committee on proficiency standards for clinical pulmonary function laboratories, ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166(1):111-117. AmericanThoracicSociety.
53. Hill K, Wickerson LM, Woon LJ, Abady AH, Overend TJ, Goldstein RS, Brooks D. The 6-min walk test: responses in healthy Canadians aged 45 to 85 years. Appl Physiol Nutr Metab 2011, 36(5):643-649. 10.1139/h11-075, 21967531.
54. van der Leeden M, van der Esch M. Optimal physiotherapeutic interventions [Optimale fysiotherapeutische interventies]. FysioPraxis 2010, 19(9):26-29.
55. Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD 2010, 7(3):214-228. 10.3109/15412555.2010.481697, 20486821.